Insider Selling: Privia Health Group, Inc. (NASDAQ:PRVA) CEO Sells 13,773 Shares of Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 13,773 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $24.99, for a total value of $344,187.27. Following the sale, the chief executive officer now owns 423,143 shares of the company’s stock, valued at approximately $10,574,343.57. This represents a 3.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

Parth Mehrotra also recently made the following trade(s):

• On Wednesday, April 30th, Parth Mehrotra sold 15,100 shares of Privia Health Group stock. The stock was sold at an average price of $23.33, for a total value of $352,283.00.

Privia Health Group Stock Performance

NASDAQ:PRVA opened at $24.30 on Thursday. The firm has a market capitalization of $2.95 billion, a PE ratio of 243.02, a PEG ratio of 3.47 and a beta of 0.87. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $26.09. The firm’s fifty day simple moving average is $23.32 and its 200 day simple moving average is $22.42.

Institutional Investors Weigh In On Privia Health Group

Hedge funds have recently bought and sold shares of the company. Durable Capital Partners LP increased its stake in shares of Privia Health Group by 3.4% in the fourth quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company’s stock worth $224,587,000 after purchasing an additional 378,255 shares during the period. Riverbridge Partners LLC grew its holdings in Privia Health Group by 19.7% in the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock valued at $113,868,000 after buying an additional 958,418 shares during the last quarter. Van Berkom & Associates Inc. bought a new position in Privia Health Group in the 1st quarter worth approximately $45,207,000. Nuveen Asset Management LLC lifted its holdings in shares of Privia Health Group by 19.8% during the fourth quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company’s stock worth $29,110,000 after buying an additional 246,393 shares during the last quarter. Finally, Northern Trust Corp boosted its position in shares of Privia Health Group by 2.2% in the first quarter. Northern Trust Corp now owns 1,423,865 shares of the company’s stock valued at $31,966,000 after acquiring an additional 31,224 shares during the period. 94.48% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently issued reports on PRVA. JMP Securities reiterated a “market outperform” rating and set a $29.00 price target on shares of Privia Health Group in a report on Monday, April 28th. Needham & Company LLC reiterated a “buy” rating and issued a $30.00 target price on shares of Privia Health Group in a research note on Thursday, April 10th. Barclays increased their price target on shares of Privia Health Group from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Thursday, April 10th. Canaccord Genuity Group lifted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, February 28th. Finally, Truist Financial upped their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a “buy” rating in a report on Thursday, April 10th. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, Privia Health Group currently has a consensus rating of “Buy” and an average target price of $27.38.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.